Jackson Square Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$504K Hold
1,195
– – 0.08% 107
2026
Q2
$433K Sell
1,195
-83
-6% -$28.4K 0.06% 107
2026
Q1
$450K Buy
+1,278
New +$456K 0.09% 101
2020
Q4
– Sell
-261
Closed -$66K – 156
2020
Q3
$66K Hold
261
– – 0.03% 168
2020
Q2
$62K Sell
261
-31
-11% -$7.07K 0.03% 153
2020
Q1
$59K Buy
292
+14
+5% +$3.06K 0.05% 113
2019
Q4
$67K Buy
+278
New +$61.3K 0.04% 140

Other funds holding AMGN

Jackson Square Capital's AMGN Position: Q3 2026 in Review

Jackson Square Capital held its Amgen (AMGN) position steady in Q3 2026 at 1,195 shares worth $504K. The position accounts for 0.08% of the portfolio, ranked #107.

Jackson Square Capital first reported a position in AMGN in Q4 2019 and has held it in 7 quarters since. 876 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Jackson Square Capital held 1,195 shares of Amgen worth $504K as of Q3 2026.
  • Jackson Square Capital left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.08% of Jackson Square Capital's portfolio in Q3 2026, its #107 holding.
  • Jackson Square Capital first reported a position in Amgen in Q4 2019 and has held it in 7 quarters since.
  • 876 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.